Skip to main content

Vida Ventures Advisors, LLC

SEC CIK
0001831423
Latest filing
Nov 3, 2025

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
8
−1 vs. Q2 2021
Portfolio value
$349.2M
−$49.7M (−12.5%) vs. Q2 2021
Filed
Nov 12, 2021
SEC
Holdings of Vida Ventures Advisors, LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS3,931,818$65.7M18.8%00.0%UnchangedHistory
KNTEKinnate Biopharma Inc.COM2,747,433$63.2M18.1%00.0%UnchangedHistory
KRONKronos Bio, Inc.COM2,765,314$58.0M16.6%00.0%UnchangedHistory
PRAXPraxis Precision Medicines, Inc.COM2,939,329$54.3M15.6%00.0%UnchangedHistory
DYNDyne Therapeutics, Inc.COM2,960,046$48.1M13.8%00.0%UnchangedHistory
ALLOAllogene Therapeutics, Inc.COM1,798,163$46.2M13.2%00.0%UnchangedHistory
OYSTOyster Point Pharma, Inc.COM640,070$7.58M2.2%−18,398−2.8%ReducedHistory
QTTBQ32 Bio Inc.COM770,845$6.07M1.7%00.0%UnchangedHistory

Sold out since Q2 2021 (1)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Vida Ventures Advisors, LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
ASMBAssembly Biosciences, Inc.COM384,635$1.49M0.4%History